Trial Profile
A Propensity-Matched Retrospective Cohort Study of Antidepressant Drug Exposure and Risk of Suicide Attempt in Adults From a Large U.S. Managed Care Population.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Antidepressants; Serotonin uptake inhibitors; Tricyclic antidepressants; Venlafaxine
- Indications Depressive disorders
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 19 Feb 2009 Actual patient numbers (254432) added as reported by ClinicalTrials.gov.
- 19 Feb 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 19 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.